/TSMRF
TSMRF Stock - Tsumura & Co.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$23.20+0.00%
+$0.00 (+0.00%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.39
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $25.52
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TSMRF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$22.97 – $23.43
TARGET (TP)$26.68
STOP LOSS$21.34
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.08
52W High$28.15
52W Low$23.20
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $181.09B | $150.84B | $140.04B | $129.55B | $116.41B |
| Gross Profit | $90.58B | $68.82B | $68.28B | $66.47B | $60.46B |
| Gross Margin | 50.0% | 45.6% | 48.8% | 51.3% | 51.9% |
| Operating Income | $40.13B | $20.02B | $20.92B | $22.38B | $19.38B |
| Net Income | $32.43B | $16.71B | $16.48B | $18.84B | $15.33B |
| Net Margin | 17.9% | 11.1% | 11.8% | 14.5% | 13.2% |
| EPS | $427.15 | $219.82 | $215.63 | $246.21 | $200.40 |
Company Overview
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TSMRFBeat Rate
56%
Last 9 quarters
Avg Surprise
-1.0%
EPS vs Estimate
Beats / Misses
5/4
Last 12 quarters
Latest EPS
$0.00
Q4 2025
EPS Surprise History
Q1 24
+43.2%
$0.67vs$0.47
Q2 24
+23.7%
$0.05vs$0.04
Q3 24
+57.8%
$0.92vs$0.58
Q4 24
-11.1%
$0.58vs$0.65
Q1 25
+27.6%
$0.76vs$0.59
Q2 25
-36.0%
$0.53vs$0.83
Q3 25
-36.4%
$0.40vs$0.63
Q4 25
-99.2%
$0.00vs$0.61
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 6, 2026 | — | — | — | — |
Q4 2025 | Nov 10, 2025 | $0.61 | $0.00 | -99.2% | ✗ MISS |
Q3 2025 | Aug 5, 2025 | $0.63 | $0.40 | -36.4% | ✗ MISS |
Q2 2025 | May 12, 2025 | $0.83 | $0.53 | -36.0% | ✗ MISS |
Q1 2025 | Feb 4, 2025 | $0.59 | $0.76 | +27.6% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $0.65 | $0.58 | -11.1% | ✗ MISS |
Q3 2024 | Aug 5, 2024 | $0.58 | $0.92 | +57.8% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.04 | $0.05 | +23.7% | ✓ BEAT |
Q1 2024 | Feb 7, 2024 | $0.47 | $0.67 | +43.2% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.34 | $0.41 | +21.8% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | — | $0.39 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.06 | — | — |
Q1 2023 | Feb 3, 2023 | — | $52.17 | — | — |
Q4 2022 | Nov 4, 2022 | — | $68.77 | — | — |
Q3 2022 | Aug 3, 2022 | — | $86.68 | — | — |
Q2 2022 | May 10, 2022 | — | $45.06 | — | — |
Q1 2022 | Feb 4, 2022 | — | $70.89 | — | — |
Q4 2021 | Nov 5, 2021 | — | $59.82 | — | — |
Q3 2021 | Aug 5, 2021 | — | $70.44 | — | — |
Q2 2021 | May 11, 2021 | — | $25.83 | — | — |
Latest News
Loading news...
Frequently Asked Questions about TSMRF
What is TSMRF's current stock price?
Tsumura & Co. (TSMRF) is currently trading at $23.20 per share. The stock has moved +0.00% today.
What is the analyst price target for TSMRF?
No analyst price targets are currently available for this stock.
What sector is Tsumura & Co. in?
Tsumura & Co. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is TSMRF's market cap?
Tsumura & Co. has a market capitalization of $1.72 billion, making it a small-cap company.
Does TSMRF pay dividends?
No, Tsumura & Co. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARSUF
Fagron N.V.
$23.50
Mkt Cap: $1.7B
CASBF
CanSino Biologics Inc.
$4.28
Mkt Cap: $1.5B
CHSYF
China Medical System Holdings Limited
$1.35
Mkt Cap: $3.3B
CURLF
Curaleaf Holdings, Inc.
$3.02
Mkt Cap: $2.3B
DMPHF
Dermapharm Holding SE
$39.56
Mkt Cap: $2.1B
HMDCF
HUTCHMED (China) Limited
$3.66
Mkt Cap: $3.1B
HTSUF
Hisamitsu Pharmaceutical Co., Inc.
$29.00
Mkt Cap: $2.1B
LBTSF
Almirall, S.A.
$15.47
Mkt Cap: $3.3B
NPNKF
Nippon Shinyaku Co., Ltd.
$30.51
Mkt Cap: $2.1B
SHPHF
Sihuan Pharmaceutical Holdings Group Ltd.
$0.16
Mkt Cap: $1.5B
Explore stocks similar to TSMRF for comparison